Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT)

go back to reference Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, Hahn T, Jakubowski A, Joffe S, Lazarus HM, Parsons SK, Robien K, Lee SJ, Kuntz KM (2013) Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Tr 19:1498–1501CrossRef Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, Hahn T, Jakubowski A, Joffe S, Lazarus HM, Parsons SK, Robien K, Lee SJ, Kuntz KM (2013) Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Tr 19:1498–1501CrossRef

go back to reference Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, Kent EE, Jacobsen PB, Lee SJ, Hsieh MM, Denzen EM, Syrjala KL (2017) National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant 23:538–551CrossRefPubMed Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, Kent EE, Jacobsen PB, Lee SJ, Hsieh MM, Denzen EM, Syrjala KL (2017) National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant 23:538–551CrossRefPubMed

go back to reference Bevans MF, Mitchell SA, Barrett JA, Bishop MR, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L, Yang L (2014) Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biol Blood Marrow Tr 20:387–395CrossRef Bevans MF, Mitchell SA, Barrett JA, Bishop MR, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L, Yang L (2014) Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biol Blood Marrow Tr 20:387–395CrossRef

go back to reference Syrjala KL, Martin PJ, Lee SJ (2012) Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol 30:3746–3751CrossRefPubMedPubMedCentral Syrjala KL, Martin PJ, Lee SJ (2012) Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol 30:3746–3751CrossRefPubMedPubMedCentral

go back to reference Im A, Mitchell SA, Steinberg SM, Curtis L, Berger A, Baird K, Kuzmina Z, Joe G, Comis LE, Juckett M, Avila D, Baruffaldi J, Masuch L, Pirsl F, Pavletic SZ (2016) Prevalence and determinants of fatigue in patient with moderate to severe chronic GvHD. Bone Marrow Transplant 51:705–712CrossRefPubMed Im A, Mitchell SA, Steinberg SM, Curtis L, Berger A, Baird K, Kuzmina Z, Joe G, Comis LE, Juckett M, Avila D, Baruffaldi J, Masuch L, Pirsl F, Pavletic SZ (2016) Prevalence and determinants of fatigue in patient with moderate to severe chronic GvHD. Bone Marrow Transplant 51:705–712CrossRefPubMed

go back to reference Norkin M, Hsu JW, Wingard JR (2012) Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol 49:104–109CrossRefPubMed Norkin M, Hsu JW, Wingard JR (2012) Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol 49:104–109CrossRefPubMed

go back to reference Larsen PD (2016) Psychosocial adjustment. In: Lubkins IM, Larsen PD (eds) Chronic illness: impact and intervention. Jones & Bartlett Learning, Burlington, MA, pp 43–62 Larsen PD (2016) Psychosocial adjustment. In: Lubkins IM, Larsen PD (eds) Chronic illness: impact and intervention. Jones & Bartlett Learning, Burlington, MA, pp 43–62

go back to reference Battiwalla M, Hashmi S, Majhail N, Pavletic S, Savani BN, Shelburne N (2017) National Institutes of Health hematopoietic cell transplantation late effects initiative: developing recommendations to improve survivorship and long-term outcomes. Biol Blood Marrow Tr 23:6–9CrossRef Battiwalla M, Hashmi S, Majhail N, Pavletic S, Savani BN, Shelburne N (2017) National Institutes of Health hematopoietic cell transplantation late effects initiative: developing recommendations to improve survivorship and long-term outcomes. Biol Blood Marrow Tr 23:6–9CrossRef

go back to reference Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, for the Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT), Sociedade Brasileira de Transplante de Medula Ossea (SBTMO) (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Tr 18:348–371CrossRef Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, for the Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT), Sociedade Brasileira de Transplante de Medula Ossea (SBTMO) (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Tr 18:348–371CrossRef

go back to reference Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM (2000) Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Tr 6:576–591CrossRef Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM (2000) Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Tr 6:576–591CrossRef

go back to reference Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP, Nachbaur D (2005) Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 74:304–308CrossRefPubMed Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP, Nachbaur D (2005) Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 74:304–308CrossRefPubMed

go back to reference Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology 18:113–127CrossRefPubMedPubMedCentral Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology 18:113–127CrossRefPubMedPubMedCentral

go back to reference Bartley EJ, Edmond SN, Wren AA, Somers TJ, Teo I, Zhou SC, Rowe KA, Abernethy AP, Keefe FJ, Shelby RA (2014) Holding back moderates the association between health symptoms and social well-being in patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manag 48:374–384CrossRef Bartley EJ, Edmond SN, Wren AA, Somers TJ, Teo I, Zhou SC, Rowe KA, Abernethy AP, Keefe FJ, Shelby RA (2014) Holding back moderates the association between health symptoms and social well-being in patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manag 48:374–384CrossRef

go back to reference Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Frassoni F, Bacigalupo A (2000) Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 110:614–619CrossRefPubMed Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Frassoni F, Bacigalupo A (2000) Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 110:614–619CrossRefPubMed

go back to reference Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR (2008) Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with care-matched controls at 5 years. Blood 111:989–996CrossRefPubMedPubMedCentral Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR (2008) Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with care-matched controls at 5 years. Blood 111:989–996CrossRefPubMedPubMedCentral

go back to reference Wong FL, Francisco L, Togawa K, Kim H, Bosworth A, Atencio L, Hanby C, Grant M, Kandeel F, Forman SJ, Bhatia S (2013) Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation. Blood 122:3973–3981CrossRefPubMedPubMedCentral Wong FL, Francisco L, Togawa K, Kim H, Bosworth A, Atencio L, Hanby C, Grant M, Kandeel F, Forman SJ, Bhatia S (2013) Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation. Blood 122:3973–3981CrossRefPubMedPubMedCentral

go back to reference Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR (2005) Long-term health-related quality of life, growth and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23:599–608CrossRefPubMed Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR (2005) Long-term health-related quality of life, growth and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23:599–608CrossRefPubMed

go back to reference Wingard JR, Vogelsang GB, Deeg HJ (2002) Stem cell transplantation: supportive care and long-term complications. Hematology Am Soc Hematol Educ Program 2002:422–444CrossRef Wingard JR, Vogelsang GB, Deeg HJ (2002) Stem cell transplantation: supportive care and long-term complications. Hematology Am Soc Hematol Educ Program 2002:422–444CrossRef

go back to reference Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33:721–727 Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33:721–727

go back to reference Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 34:257–266CrossRefPubMed Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 34:257–266CrossRefPubMed

go back to reference Jafari H, Jannati Y, Nesheli HM, Hassanpour S (2017) Effects of nonpharmacological interventions on reducing fatigue after hematopoietic stem cell transplantation. J Res Med Sci 22:13CrossRefPubMedPubMedCentral Jafari H, Jannati Y, Nesheli HM, Hassanpour S (2017) Effects of nonpharmacological interventions on reducing fatigue after hematopoietic stem cell transplantation. J Res Med Sci 22:13CrossRefPubMedPubMedCentral

go back to reference Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B, Passweg J, Miralbell R, Chalandon Y (2008) Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 42:819–827CrossRefPubMed Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B, Passweg J, Miralbell R, Chalandon Y (2008) Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 42:819–827CrossRefPubMed

go back to reference Esser P, Kuba K, Mehnert A, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander AR, Kroger N, Schilling G, Gotze H, Scherwath A (2017) Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT. Bone Marrow Transplant 52:753–758CrossRefPubMed Esser P, Kuba K, Mehnert A, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander AR, Kroger N, Schilling G, Gotze H, Scherwath A (2017) Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT. Bone Marrow Transplant 52:753–758CrossRefPubMed

go back to reference Gielissen MFM, Schattenberg AVM, Verhagen CAHHVM, Rinkes MJ, Bremmers MEJ, Bleijenberg G (2007) Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 39:595–603CrossRefPubMed Gielissen MFM, Schattenberg AVM, Verhagen CAHHVM, Rinkes MJ, Bremmers MEJ, Bleijenberg G (2007) Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 39:595–603CrossRefPubMed

go back to reference Jim HSL, Sutton SK, Jacobsen PB, Martin PJ, Flowers ME, Lee SJ (2016) Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer 122:1290–1297CrossRefPubMed Jim HSL, Sutton SK, Jacobsen PB, Martin PJ, Flowers ME, Lee SJ (2016) Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer 122:1290–1297CrossRefPubMed

go back to reference LaVoy ECP, Fagundes CP, Dantzser R (2016) Exercise, inflammation, and fatigue in cancer survivors. Exerc Immunol Rev 22:82–93PubMedPubMedCentral LaVoy ECP, Fagundes CP, Dantzser R (2016) Exercise, inflammation, and fatigue in cancer survivors. Exerc Immunol Rev 22:82–93PubMedPubMedCentral

go back to reference Munir F, Yarker J, McDermott H (2009) Employment and the common cancers: correlates of work ability during or following cancer treatment. Occup Med (Lond) 59:381–389CrossRef Munir F, Yarker J, McDermott H (2009) Employment and the common cancers: correlates of work ability during or following cancer treatment. Occup Med (Lond) 59:381–389CrossRef

go back to reference Morrison EJ, Ehlers SL, Bronars CA, Patten CA, Brockman TA, Cerhan JR, Hogan WJ, Hashmi SK, Gastineau DA (2016) Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biol Blood Marrow Tr 22:1690–1169CrossRef Morrison EJ, Ehlers SL, Bronars CA, Patten CA, Brockman TA, Cerhan JR, Hogan WJ, Hashmi SK, Gastineau DA (2016) Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biol Blood Marrow Tr 22:1690–1169CrossRef

go back to reference Bevans MF, Mitchell SA, Barrett AJ, Bishop M, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L (2011) Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol. Health Qual Life Outcomes 9:24CrossRefPubMedPubMedCentral Bevans MF, Mitchell SA, Barrett AJ, Bishop M, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L (2011) Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol. Health Qual Life Outcomes 9:24CrossRefPubMedPubMedCentral

go back to reference Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912–2919CrossRefPubMedPubMedCentral Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912–2919CrossRefPubMedPubMedCentral

go back to reference Cella D (2004) Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, version 4.1. Center of Outcomes, Research, and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL Cella D (2004) Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, version 4.1. Center of Outcomes, Research, and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL

go back to reference Van Belle S, Paridaens R, Evers G, Kerger J, Bron D, Foubert J, Ponnet G, Steichel DV, Heremans C, Rosillon D (2005) Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 13:246–254CrossRefPubMed Van Belle S, Paridaens R, Evers G, Kerger J, Bron D, Foubert J, Ponnet G, Steichel DV, Heremans C, Rosillon D (2005) Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 13:246–254CrossRefPubMed

go back to reference Derogatis LR (1986) The psychosocial adjustment to illness scale (PAIS). J Psychosom Res 30:77–91CrossRefPubMed Derogatis LR (1986) The psychosocial adjustment to illness scale (PAIS). J Psychosom Res 30:77–91CrossRefPubMed

go back to reference IBM Corp. (2012) IBM SPSS statistics for Windows, version 21.0. IBM Corp.: Armonk, NY IBM Corp. (2012) IBM SPSS statistics for Windows, version 21.0. IBM Corp.: Armonk, NY

go back to reference Molassiotis A, vandenAkker OBA, Milligan DW, Goldman JM, Boughton BJ, Holmes JA, Thomas S (1996) Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 17:249–258 Molassiotis A, vandenAkker OBA, Milligan DW, Goldman JM, Boughton BJ, Holmes JA, Thomas S (1996) Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 17:249–258

go back to reference Khera N, Zeliadt SB, Lee SJ (2012) Economics of hematopoietic cell transplantation. Blood 120:1545–1551CrossRefPubMed Khera N, Zeliadt SB, Lee SJ (2012) Economics of hematopoietic cell transplantation. Blood 120:1545–1551CrossRefPubMed

go back to reference Majhail NS (2017) Long-term complications after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. https://doi.org/10.1016/j.hemonc.2017.05.009 Majhail NS (2017) Long-term complications after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. https://​doi.​org/​10.​1016/​j.​hemonc.​2017.​05.​009

go back to reference Langer SL, Yi JC, Storer BE, Syrjala KL (2010) Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: a prospective, five-year longitudinal investigation. Psycho-Oncology 19:190–200CrossRefPubMedPubMedCentral Langer SL, Yi JC, Storer BE, Syrjala KL (2010) Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: a prospective, five-year longitudinal investigation. Psycho-Oncology 19:190–200CrossRefPubMedPubMedCentral

go back to reference Hashmi SK, Srivastava A, Rasheed W, Adil S, Wu T, Jagasia M, Nassar A, Hwang WYK, Hamidieh AA, Greinix HT, Pasquini MC, Apperley JF, Aljurf M (2017) Cost and quality issues in establishing hematopoietic cell transplant program in developing countries. Hematol Oncol Stem Cell Ther. https://doi.org/10.1016/j.hemonc.2017.05.017 Hashmi SK, Srivastava A, Rasheed W, Adil S, Wu T, Jagasia M, Nassar A, Hwang WYK, Hamidieh AA, Greinix HT, Pasquini MC, Apperley JF, Aljurf M (2017) Cost and quality issues in establishing hematopoietic cell transplant program in developing countries. Hematol Oncol Stem Cell Ther. https://​doi.​org/​10.​1016/​j.​hemonc.​2017.​05.​017

go back to reference Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psycho-Oncology 13:147–160CrossRefPubMed Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psycho-Oncology 13:147–160CrossRefPubMed

go back to reference Helgeson VS, Reynolds KA, Tomich PL (2006) A meta-analytic review of benefit finding and growth. J Consult Clin Psychol 74:797–816CrossRefPubMed Helgeson VS, Reynolds KA, Tomich PL (2006) A meta-analytic review of benefit finding and growth. J Consult Clin Psychol 74:797–816CrossRefPubMed

go back to reference Kirchhoff AC, Leisenring W, Syrjala KL (2010) Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 4:33–44CrossRefPubMedPubMedCentral Kirchhoff AC, Leisenring W, Syrjala KL (2010) Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 4:33–44CrossRefPubMedPubMedCentral

go back to reference Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML (2015) Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Biol Blood Marrow Tr 21:151–158CrossRef Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML (2015) Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Biol Blood Marrow Tr 21:151–158CrossRef

go back to reference Berger AM, Mitchell SA, Jacobsen PB, Pirl WF (2015) Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice? CA Cancer J Clin 65:190–211CrossRefPubMed Berger AM, Mitchell SA, Jacobsen PB, Pirl WF (2015) Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice? CA Cancer J Clin 65:190–211CrossRefPubMed

go back to reference Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA (2016) NCCN guidelines (R) insights survivorship, version 1.2016 featured updates to the NCCN guidelines J Natl Compr Canc Netw 14:715-724 Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA (2016) NCCN guidelines (R) insights survivorship, version 1.2016 featured updates to the NCCN guidelines J Natl Compr Canc Netw 14:715-724